RPGRIP1L and obesity disorder: Targeted deletion of Irx3 in mice results in reduced body size and resistance to HFD-induced obesity [4], whereas mice heterozygous for a deletion in Ftm (also Rpgrip1l) results in increase of body-weight [5].